Novel Combinations
    2.
    发明申请
    Novel Combinations 审中-公开
    新组合

    公开(公告)号:US20090304634A1

    公开(公告)日:2009-12-10

    申请号:US12518336

    申请日:2007-12-10

    CPC分类号: A61K31/415 A61K31/40

    摘要: Invented is a method of treating viral diseases, particularly hepatitis C, in a human, in need thereof which comprises the administration of a combination of therapeutically active agents selected from a TPO receptor agonist and an antiviral therapy selected from: an alpha interferon, ribavirin, a ribavirin analog and an HCV antiviral to such human.

    摘要翻译: 本发明是一种在有需要的人中治疗病毒性疾病,特别是丙型肝炎的方法,其包括施用选自以下的治疗活性剂的组合:TPO受体激动剂和选自以下的抗病毒疗法:α干扰素,利巴韦林, 利巴韦林类似物和HCV抗病毒药物。